BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

ILEX Oncology, Inc. 

4545 Horizon Hill Boulevard

San Antonio  Texas  78229-2263  U.S.A.
Phone: 210-949-8200 Fax: 210-949-8210


SEARCH JOBS


Industry
Pharmaceutical

Segment
Oncology

Collaborations

Millennium: The Takeda Oncology Company  Development of CAMPATH.

Schering AG  Together with Millennium Pharmaceuticals, Inc., ILEX has entered into a distribution and development agreement with Schering AG to market CAMPATH worldwide except for Japan and East Asia.

IMPATH Inc.  ILEX's strategic relationship with IMPATH, Inc. is focused on enhancing the Company's clinical trial design capabilities.

Symphar S.A.  Development of APOMINE (SR-45023A).





 Company News
Genzyme Corporation (GENZ) Completes Acquisition Of ILEX Oncology, Inc. (GENZ) 10/19/2005 5:12:30 PM    More...
Additional Patients Support Clofarabine Promise; ILEX Oncology, Inc. (ILXO) Expects FDA Decision On NDA Filing By Year End 10/19/2005 5:12:23 PM    More...
Bioenvision (BIOV) Release: Clofarabine Achieves High Response Rates In Acute Myeloid Leukaemia -AML-; Three Fold Increase In Response Rates Compared With Current Standard Of Care 10/19/2005 5:12:22 PM    More...
ILEX Oncology, Inc. (ILXO) Drug Helps One Leukemia, Not Another -US Panel 10/19/2005 5:12:21 PM    More...
ILEX Oncology, Inc. (ILXO) Release: FDA Advisory Committee Recommends Accelerated Clofarabine Approval For Most Common Pediatric Leukemia 10/19/2005 5:12:20 PM    More...
FDAAdvisoryCommittee.com To Webcast Dec. 1-2 Reviews Of Procter & Gamble's (PG) Sexual Dysfunction Drug Intrinsa, ILEX Oncology, Inc.' (ILXO) Clolar For Leukemia, And INEX Pharmaceuticals (IEX.TO) / Enzon Pharmaceuticals, Inc.'s (ENZN) Marqibo For Lymphoma 10/19/2005 5:12:19 PM    More...
ILEX Oncology (ILXO) Reports Q3 2004 Results; Clofarabine FDA Panel Hearing Set For December 10/19/2005 5:11:52 PM    More...
Berlex Inc. And ILEX Oncology (ILXO) Release: CAMPATH(R) (Alemtuzumab For Injection) Approved For Marketing In New Single-Use Vial 10/19/2005 5:11:51 PM    More...
Bioenvision's (BIOV) Clofarabine Data Presented At Leading Hematology Congress; Durable Responses Reported At Leukemia 2004 Houston, Texas 10/19/2005 5:11:49 PM    More...
ILEX Oncology (ILXO) Updates Clofarabine NDA With Encouraging Results; Additional Patient Data Resets FDA Action Date 10/19/2005 5:11:41 PM    More...
12345

//-->